中国和意大利在深圳设立联合实验室,推进药物研究和免疫疗法。 China and Italy launch joint lab in Shenzhen to advance pharmaceutical research and immunotherapy.

中国和意大利在深圳建立了一个新的联合实验室,以推动制药生物技术和免疫安全的研究。 A new joint laboratory between China and Italy has been set up in Shenzhen to advance research in pharmaceutical biotechnology and immunosafety. 实验室是两国机构之间的合作,将侧重于评价物质的毒性和开发免疫疗法药物。 The lab, a collaboration between institutions from both countries, will focus on evaluating the toxicity of substances and developing immunotherapy drugs. 该倡议旨在促进生物制药的国际科学合作和创新。 This initiative aims to boost international scientific cooperation and innovation in biopharmaceuticals.